Insider Transactions in Q2 2025 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2025
|
Eliyahu Sharon Kalif EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
55,775
-12.15%
|
$948,175
$17.08 P/Share
|
|
Jun 06
2025
|
Janet S. Vergis |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+11.56%
|
-
|
|
Jun 06
2025
|
Varda Shalev |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+29.97%
|
-
|
|
Jun 06
2025
|
Tal Zvi Zaks |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+14.08%
|
-
|
|
Jun 06
2025
|
Perry Nisen |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+8.38%
|
-
|
|
Jun 06
2025
|
Ronit Satchi Fainaro |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+8.96%
|
-
|
|
Jun 06
2025
|
Rosemary A Crane |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+7.84%
|
-
|
|
Jun 06
2025
|
Amir Elstein |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+0.46%
|
-
|
|
Jun 06
2025
|
Gerald M Lieberman |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+7.69%
|
-
|
|
Jun 06
2025
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,158
+3.87%
|
-
|
|
Jun 06
2025
|
Roberto Mignone |
BUY
Exercise of conversion of derivative security
|
Direct |
9,632
+8.38%
|
-
|
|
Jun 03
2025
|
Matthew Shields EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
6,206
-38.32%
|
$105,502
$17.02 P/Share
|
|
Jun 03
2025
|
Matthew Shields EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,195
+50.0%
|
-
|
|
May 08
2025
|
Mark Sabag |
SELL
Open market or private sale
|
Direct |
337,915
-69.12%
|
$6,082,470
$18.04 P/Share
|